This inventor holds 3 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, Other. Active years: 1984-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,217 
2 out of 834,570 Years Active: 1984-2003
Title: Edward I Ginns: Innovator in Neuropsychiatric Research
Introduction
Edward I Ginns is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of neuropsychiatric disorders through his innovative research and patented inventions. With a total of 3 patents, Ginns has focused on identifying genetic polymorphisms and developing therapeutic methods.
Latest Patents
Ginns' latest patents include groundbreaking work on the identification of polymorphisms in the PCTG4 region of Xq13. This patent discloses nucleic acid sequences within the q13 region of the X chromosome that are associated with neuropsychiatric disorders and related conditions. One notable polymorphism occurs within the coding region of the HOPA gene, introducing a four amino acid insertion into a putative OPA domain, which is known to be involved in tissue-specific expression. Additionally, he has developed compositions that include nucleic acids with these polymorphisms and antibodies targeting polymorphic regions within proteins encoded in the PCTG4 region. His work also encompasses methods for diagnosing and assessing pathologies linked to neuropsychiatric disorders. Another significant patent involves the cloning of DNA for synthesizing unique glucocerebrosidase, which is produced by recombinant methods and has therapeutic applications for treating Gaucher's disease.
Career Highlights
Throughout his career, Ginns has worked with various organizations, including the United States of America as represented by the Department of Health. His research has been pivotal in advancing the understanding of genetic factors in neuropsychiatric conditions.
Collaborations
Ginns has collaborated with esteemed colleagues such as Robert Philibert and Lynn Delisi, contributing to a rich exchange of ideas and research findings in the field.
Conclusion
Edward I Ginns stands out as an influential inventor whose work has significantly impacted neuropsychiatric research. His innovative patents and collaborations continue to pave the way for advancements in understanding and treating complex disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile